The latest U.S. prescription drug sales ranking: Psychiatry
-
Last Update: 2014-08-04
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: according to the latest data released by IMS Health on August 4, 2014, the top 100 prescription drugs with the largest prescription volume and the highest sales volume in the United States in the past year (July 2013 June 2014) have little change compared with the whole year of 2013, with syntroid and abilifly , Otsuka) won the championship of prescription quantity and sales respectively Yimaitong psychiatry department summarized the psychiatry drugs in the top 100 list of prescription drugs for reference Prescription volume: sales volume: in terms of overall ranking, the top 10 prescription volumes are: syntroid (Albright), cholesterol lowering drug Crestor (AstraZeneca), proton pump inhibitor Nexium (AstraZeneca), antiasthmatic drug salbutamol (ventolinhfa) , GlaxoSmithKline, fluticasone propionate / salmeterol inhaler (advairdiskus, GlaxoSmithKline), depressor valsartan (Devon, Novartis), hypoglycemic agent insulin glargine injection (Sanofi Aventis when it comes), antidepressant duloxetine (xinbaida, Lilly), attention deficit drug ryvanse , shire) and antiepileptic drug Lyrica (Pfizer) The top 10 sales figures are: abilifly, Otsuka, Humira, Nexium, Crestor , AstraZeneca, etanercept, fluticasone propionate / salmeterol (advair Diskus, GlaxoSmithKline), sovaldi, centricor )The antidiabetic drug, insulin glargine injection (Sanofi Aventis when it came) and the white drug, polyethylene glycol, feulasta (Anjin company).
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.